Ventyx Biosciences Stock In The News

VTYX Stock  USD 1.41  0.02  1.44%   
Our overall analysis of Ventyx Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Ventyx Biosciences. The specific impact of Ventyx Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ventyx Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ventyx Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ventyx Biosciences Backtesting and Ventyx Biosciences Hype Analysis.
For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Ventyx Biosciences Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
https://www.globenewswire.com/news-release/2025/02/18/3027755/0/en/Ventyx-Biosciences-Announces-Presentation-of-Data-from-the-Phase-2-Trial-of-Allosteric-TYK2-Inhibitor-VTX958-in-Crohn-s-Disease-at-ECCO-2025.html
 Neutral
Macroaxis News: globenewswire.com
Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/21/2784417/0/en/Ventyx-Biosciences-to-Participate-in-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/10/2778264/0/en/Ventyx-Biosciences-to-Participate-in-the-Jefferies-London-Healthcare-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Ventyx Biosciences Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Progress
https://www.globenewswire.com/news-release/2023/11/09/2777779/0/en/Ventyx-Biosciences-Reports-Third-Quarter-2023-Financial-Results-and-Highlights-Recent-Corporate-Progress.html
 Neutral
Macroaxis News: globenewswire.com
Ventyx Biosciences Announces Results fro...
https://www.globenewswire.com/news-release/2023/11/06/2774464/0/en/Ventyx-Biosciences-Announces-Results-from-the-Phase-2-Trial-of-VTX958-in-Patients-with-Moderate-to-Severe-Plaque-Psoriasis-and-Provides-Corporate-Update.html
 Neutral
Yahoo News
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
https://finance.yahoo.com/news/12-best-small-cap-biotech-161629611.html
 Bullish
Yahoo News
Why Shares of Ventyx Biosciences Are Dropping Tuesday
https://finance.yahoo.com/m/8902df8c-b5e5-389a-b12e-2e75fc9ce150/why-shares-of-ventyx.html
 Neutral
Macroaxis News: globenewswire.com
Ventyx Biosciences Announces Positive Re...
https://www.globenewswire.com/news-release/2023/10/09/2757021/0/en/Ventyx-Biosciences-Announces-Positive-Results-from-the-Phase-2-Trial-of-VTX002-in-Patients-with-Moderate-to-Severely-Active-Ulcerative-Colitis.html
 Bullish
Yahoo News
25 Biggest Stocks with Negative Beta
https://finance.yahoo.com/news/25-biggest-stocks-negative-beta-164310739.html
 Neutral
Macroaxis News: globenewswire.com
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2023/08/30/2734783/0/en/Ventyx-Biosciences-to-Participate-in-Two-Upcoming-Investor-Conferences.html
 Bullish

Ventyx Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ventyx and other traded companies coverage with news coverage. We help investors stay connected with Ventyx headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Ventyx Stock performance. Please note that trading solely based on the Ventyx Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ventyx Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ventyx Biosciences investors visualize upcoming and past events in order to time the market based on Ventyx Biosciences noise-free hype analysis.
Ventyx Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ventyx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ventyx Biosciences that are available to investors today. That information is available publicly through Ventyx media outlets and privately through word of mouth or via Ventyx internal channels. However, regardless of the origin, that massive amount of Ventyx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ventyx Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ventyx Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ventyx Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ventyx Biosciences alpha.

Ventyx Largest EPS Surprises

Earnings surprises can significantly impact Ventyx Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-15
2022-06-30-0.45-0.390.0613 
2024-05-09
2024-03-31-0.69-0.620.0710 
2022-05-12
2022-03-31-0.52-0.450.0713 
2024-02-27
2023-12-31-0.9-0.790.1112 
2024-08-09
2024-06-30-0.5743-0.450.124321 
2025-02-28
2024-12-31-0.5457-0.410.135724 
View All Earnings Estimates

Ventyx Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ventyx Biosciences Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
12th of March 2025
Acquisition by Matthew Moore of 320000 shares of Ventyx Biosciences at 4.98 subject to Rul...
at MacroaxisInsider 
Google News at Macroaxis
3rd of March 2025
Class Action Filed Against Ventyx Biosciences, Inc. - April 30, 2024 Deadline to Join - Co...
at news.google.com 
Gurufocus Stories at Macroaxis
27th of February 2025
Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlig...
at gurufocus.com 
Macroaxis News: globenewswire.com
18th of February 2025
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK...
at globenewswire.com 
Gurufocus Stories at Macroaxis
5th of February 2025
Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ...
at gurufocus.com 
Google News at Macroaxis
17th of January 2025
HC Wainwright Analysts Increase Earnings Estimates for VTYX - MarketBeat
at news.google.com 
Yahoo News
10th of January 2025
Were Keeping An Eye On Ventyx Biosciences Cash Burn Rate
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
31st of December 2024
Insider Sell John Nuss Sells 21,119 Shares of Ventyx Biosciences Inc
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ventyx Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ventyx Biosciences' short interest history, or implied volatility extrapolated from Ventyx Biosciences options trading.

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.